China Widens AstraZeneca Probe as Country Boss Investigated
- Probe follows detention of employees earlier this year
- Sign of Beijing intensifying scrutiny into British drugmaker
This article is for subscribers only.
AstraZeneca Plc’s China President Leon Wang is under investigation by the country’s authorities, as Beijing’s intensifying regulatory scrutiny on the British drug giant reaches its senior ranks.
Wang is cooperating and, if requested, Astra too will “fully cooperate with the investigation,” the British company said without revealing further details about the probe.